Clinical Trials Directory

Trials / Completed

CompletedNCT03267927

Management of Obstructive Sleep Apnea (OSA) in Children and Maxillary and Mandibular Development

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
4 (actual)
Sponsor
Rennes University Hospital · Academic / Other
Sex
All
Age
5 Years – 7 Years
Healthy volunteers
Not accepted

Summary

Assessment of the association of maxillary expansion using a rapid palatal expansion, use of a mandibular advancement appliance (MGA™) and of a device allowing sleep in a semi-seated position (Yoobreath™) in patients with Obstructive Sleep Apnea (OAS). MGA™ and YooBreath™ constitute the Yookid system™.

Detailed description

Obstructive Sleep Apnea syndrome (OSA) shows a 10% morbidity rate in children with a higher rate between the ages of 3 and 5. Generally speaking, its prevalence is underestimated. Furthermore, detecting OSA remains difficult due to its particular physiopathology. The decrease in nasopharyngeal airway dimensions is the most common etiology. This decrease is related to soft tissues as well as maxillomandibular abnormalities. The aim of the study is to show that reducing sleep apnea in children remains possible when inducing rapid palatal expansion and mandibular advancement using the Yookid™ system. The Yookid™ system associates a mandibular advancement appliance and repositioning of the patient during sleep.

Conditions

Interventions

TypeNameDescription
DEVICERapid palatal expansionFixation of rapid palatal expansion from day 0 to day 60
DEVICEMGA™ systemUse of a mandibular advancement Appliance during the night from day 60 to day 180 (end of treatment from day 120 if Angle Class I is obtained)
DEVICEYoobreath™ systemUse of a device allowing sleep in a semi-seated position during the night from day 15 to day 180 (end of treatment from day 120 if Angle Class I is obtained)

Timeline

Start date
2017-11-05
Primary completion
2019-03-25
Completion
2019-03-25
First posted
2017-08-31
Last updated
2020-02-07

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03267927. Inclusion in this directory is not an endorsement.